Identification of a novel HLA-B*51 variant: HLA-B*5112.

Tissue Antigens

Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint Louis, and INSERM U396, Paris, France.

Published: November 1998

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0039.1998.tb03077.xDOI Listing

Publication Analysis

Top Keywords

identification novel
4
novel hla-b*51
4
hla-b*51 variant
4
variant hla-b*5112
4
identification
1
hla-b*51
1
variant
1
hla-b*5112
1

Similar Publications

Identifying and quantifying the dominant factors influencing heavy metal (HM) pollution sources are essential for maintaining soil ecological health and implementing effective pollution control measures. This study analyzed soil HM samples from 53 different land use types in Jiaozuo City, Henan Province, China. Pollution sources were identified using Absolute Principal Component Score (APCS), with 8 anthropogenic factors, 9 natural factors, and 4 soil physicochemical properties mapped using Geographic Information System (GIS) kernel density estimation.

View Article and Find Full Text PDF

Clinical and genetic characteristics of patients with Alagille syndrome in China: identification of six novel and mutations.

Transl Pediatr

December 2024

Department of Gastroenterology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Background: Alagille syndrome (ALGS) is a rare disease. The variable clinical manifestations make the diagnosis of ALGS difficult. This study aimed to provide a basis for the early diagnosis of ALGS patients whose clinical identification is difficult and to enrich the spectrum of genetic variants implicated in Chinese children with ALGS.

View Article and Find Full Text PDF

A Phage-Based Approach to Identify Antivirulence Inhibitors of Bacterial Type IV Pili.

Microb Biotechnol

January 2025

Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, USA.

The increasing threat of antibiotic resistance underscores the urgent need for innovative strategies to combat infectious diseases, including the development of antivirulants. Microbial pathogens rely on their virulence factors to initiate and sustain infections. Antivirulants are small molecules designed to target virulence factors, thereby attenuating the virulence of infectious microbes.

View Article and Find Full Text PDF

The HLA-A*02:1098 allele differs from HLA-A*02:07:01:01 by a single non-synonymous nucleotide change in exon 3.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) have emerged as novel blood-based biomarkers for various pathologies. The development of methods to enrich cell-specific EVs from biofluids has enabled us to monitor difficult-to-access organs, such as the brain, in real time without disrupting their function, thus serving as liquid biopsy. Burgeoning evidence indicates that the contents of neuron-derived EVs (NDEs) in blood reveal dynamic alterations that occur during neurodegenerative pathogenesis, including Alzheimer's disease (AD), reflecting a disease-specific molecular signature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!